For instance, clinical trials targeting otherastrocytic secreted proteins after stroke e.g., S100-β, have shown mixed results intranslating promising preclinical findings.5 Therefore, a broader understanding of the astrocyte role in stroke should beconsidered. Here, S100B is linked to stroke disorder.